Benzinga | Nov 5, 2020 07:32AM EST

Harvard Bioscience Q3 EPS $0.04 Beats $0.03 Estimate, Sales $24.04M Miss $24.05M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $24.04 million which missed the analyst consensus estimate of $24.05 million by 0.05 percent. This is a 12.33 percent decrease over sales of $27.42 million the same period last year.